Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Biobot Analytics is a wastewater epidemiology company that analyzes sewage to track infectious diseases, substance use, and public health trends across communities. HQ: Cambridge, MA.
Biobot Analytics is a public health infrastructure company that uses wastewater epidemiology to provide early warning of infectious disease outbreaks, substance use trends, and other public health indicators to communities, public health agencies, and the federal government. Founded in 2017 by MIT graduates Mariana Matus and Newsha Ghaeli, the company became nationally prominent during the COVID-19 pandemic when its wastewater surveillance network provided some of the earliest data on SARS-CoV-2 spread in communities — often detecting outbreaks 4–7 days before clinical case reports.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.